甲状腺激素受体
线粒体融合
核受体
脂质代谢
细胞生物学
线粒体
化学
辅活化剂
下调和上调
激素
肾透明细胞癌
甲状腺激素受体β
受体
生物
细胞
脂滴
脂质积聚
细胞融合
功能(生物学)
生物化学
细胞生长
过氧化物酶体
癌症研究
过氧化物酶体增殖物激活受体
融合蛋白
甲状腺
甲状腺功能
作者
Xiangui Meng,Tiexi Yu,Fang Lv,Weiquan Li,Hongmei Yang,Xiaoping Zhang,Wen Xiao
标识
DOI:10.1002/advs.202508571
摘要
Abstract The abnormal accumulation of lipids is a hallmark of clear cell renal cell carcinoma (ccRCC). Both the thyroid hormone receptor β1 (TRβ) and peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha (PGC1α) are key regulators of mitochondrial function and lipid metabolism. However, their specific interaction and influence on ccRCC development and lipid accumulation remain poorly understood. This study identified genes jointly regulated by TRβ and PGC1α, which are implicated in lipid browning and mitochondrial fusion. Mechanistically, T3‐activated TRβ interacts with PGC1α to transcriptionally upregulate PGC1α, UCP1, and mitochondrial fusion genes OPA1 and MFN2, thereby enhancing mitochondrial activity, promoting lipid utilization, and suppressing ccRCC progression. These results indicate that the mitochondrial and metabolic effects of TRβ in ccRCC are mediated through PGC1α expression and function. Activation of the TRβ/PGC1α through hormonal and pharmacological means may offer a promising therapeutic approach for ccRCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI